ABUS vs META · P/E 5.4, rev $6.2M vs P/E 29, rev $200.97B
Arbutus Biopharma Corp (ABUS) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. META currently screens at market cap $1.64T and trailing P/E 28.8.
Not investment advice. Open the ABUS and META stock pages for the full models.
Not investment advice.